STAT3 and lung adenocarcinoma: Since various studies have now indicated an important role for the IL-6/STAT3 axis as a mediator of resistance to EGFR inhibition in lung adenocarcinomas [31, 32], we have also analyzed whether IL-6 was upregulated in the cell models utilized here.